norfloxacin has been researched along with pefloxacin in 266 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 190 (71.43) | 18.7374 |
| 1990's | 44 (16.54) | 18.2507 |
| 2000's | 21 (7.89) | 29.6817 |
| 2010's | 8 (3.01) | 24.3611 |
| 2020's | 3 (1.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, P; Cisek, EP; Cornell, CP; Elliott, NC; Gootz, TD; Haskell, SL; Hindahl, MS; Jefson, MR; Mann, DD; McGuirk, PR | 1 |
| Cohen, MA; Domagala, JM; Mailloux, GB; Roland, GE; Suto, MJ | 1 |
| Bridges, AJ; Bucsh, R; Domagala, JM; Gogliotti, RD; Hagen, SE; Heifetz, CL; Joannides, ET; Sanchez, JP; Sesnie, JC; Shapiro, MA | 1 |
| Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
| Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
| Kawakami, K; Kondo, H; Sakamoto, F; Tsukamoto, G | 1 |
| Bailey, DM; Cornett, JB; Dobson, RA; Powles, RG; Wagner, RB; Wentland, MP | 1 |
| Irikura, T; Itoh, A; Koga, H; Murayama, S; Suzue, S | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
| Baroni, M; Cecchetti, V; Cianchetta, G; Cruciani, G; Mannhold, R | 1 |
| Araya, I; Asahina, Y; Hosaka, M; Iinuma, F; Ishizaki, T; Iwase, K | 1 |
| Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Bremont, S; Charavay, F; Courvalin, P; Goarant, C; Le Hello, S; O'Connor, O; Page, S; Vernel-Pauillac, F | 1 |
| Chhasatia, MR; Gandhi, DS; Patel, MN | 1 |
| Brillault, J; Couet, W; De Castro, WV | 1 |
| Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gao, F; Wang, T; Xiao, J; Zhang, X | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Rahal, K | 2 |
| Hannan, A | 1 |
| Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Fioritoni, G; Iacone, A; Pantalone, V; Piergallini, A; Quaglietta, AM; Recchia, A | 1 |
| Ballereau, M; Chanu, D; Drévillon, C; Dru, M; Journois, D; Safran, D | 1 |
| Räisäinen, S; Schildt, R; Syrjälä, H | 1 |
| Bauchet, J; Cochereau-Massin, I; Faurisson, F; Lacombe, P; Pocidalo, JJ; Vallois, JM | 1 |
| Davidson, RJ; Hoban, DJ; Phillips, R; Zhanel, GG | 1 |
| McQueen, CA; Queener, SM; Schlüter, G; Way, BM; Williams, GM | 1 |
| Dombros, N; Nikolaidis, P; Oreopoulos, DG; Paton, TW; Tourkantonis, A; Walker, SE | 1 |
| al-Shammary, FJ; Bishop, SJ; Shibl, AM; Shoeb, HA; Tawfik, AF | 1 |
| Boeckk, M; Borner, K; Deppermann, N; Höffken, G; Koeppe, P; Lode, H | 1 |
| Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B | 1 |
| Guenounou, M; Miguères, ML; Ronco, E | 1 |
| Midtvedt, T | 1 |
| de Melker, RA; Touw-Otten, FW; van Balen, FA | 1 |
| Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Jones, RN | 1 |
| Aubert, G; Denis, M; Dorche, G; Loboguerrero, M; Lucht, F; Puech, C | 1 |
| Courvalin, P; Derlot, E; Poyart-Salmeron, C | 1 |
| Arcese, W; Gentile, G; Giuliano, M; Martino, P; Pantosti, A; Venditti, M | 1 |
| Dailloux, M; Henry, C; Petitpain, N; Weber, M | 1 |
| Shah, PM | 2 |
| Dureuil, C; Le Goffic, F; Moreau, N; Tabary, X | 1 |
| Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
| Edlund, C; Lahnborg, G; Nord, CE | 1 |
| Neu, HC | 1 |
| Charlot, J; Di Menza, C; Prieur, B | 1 |
| Hooper, DC; Wolfson, JS | 1 |
| Boerema, JB; von Summeren, TR; Willems, FT | 1 |
| Baur, C; Davies, BI; Maesen, FP; Teengs, JP | 2 |
| Boerema, JB | 1 |
| Geitz, JN; Lerk, CF; Tarko-Smit, NJ; Van Saene, HK; Van Saene, JJ | 1 |
| Brouwers, JR; Groeneveld, AJ | 1 |
| Bauchet, J; Pangon, B; Regnier, B; Rouveix, E; Vachon, F; Wolff, M | 1 |
| Edlund, C; Nord, CE | 2 |
| Klastersky, J; Van der Auwera, P | 1 |
| King, A; Phillips, I | 2 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Bouanchaud, DH; Huet, Y; Rolin, O | 1 |
| Avesani, V; Delmee, M | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Chopin, C; Fourrier, F; Lestavel, P; Savage, C | 1 |
| Baran, R; Brun, P | 1 |
| Boussougant, Y; Gaudin, H; Vinceneux, P; Weber, P | 1 |
| Amrani, R; Beklahia, C; Labia, R; Morand, A; Verchere-Beaur, C | 1 |
| Camus, P; Fur, A; Jeannin, L; Massin, F; Waldner, A | 1 |
| Baran, R; Juhlin, L | 1 |
| Bielefeld, P; Caillot, D; Guy, H; Kazmierczak, A; Portier, H; Solary, E | 1 |
| Borner, K; Lode, H | 1 |
| Høiby, N | 1 |
| Bertrand, A; Janbon, F; Jonquet, O; Reynes, J | 1 |
| Beoletto, C; Grosset, JH; Guelpa-Lauras, CC; Perani, EG | 1 |
| Brunet, J; Descos, B; Floret, D; Freney, J; Hermier, M; Lachaux, A; Loras-Duclaux, I; Souillet, G | 1 |
| Cellini, L; Oliva, B; Renzini, G; Scazzocchio, F; Schippa, S; Selan, L | 1 |
| Bauernfeind, A; Gablac, R; Heinrich, B; Petermüller, C | 1 |
| Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 2 |
| Verbist, L | 1 |
| Crokaert, F; Glupczynski, Y; Van der Linden, MP; Yourassowsky, E | 1 |
| Bernard, E; Dellamonica, P; Etesse, H; Garraffo, R | 1 |
| Husson, M; Klastersky, J; Lauzon, D; Lieppe, S; Lopez, AP; Van der Auwera, P | 1 |
| Meyran, M; Thabaut, A | 1 |
| Caillon, J; Drugeon, HB; Juvin, ME; Pirault, JL | 1 |
| Galicher, V; Perez, R; Raoult, D; Roussellier, P; Tamalet, J; Vestris, G | 1 |
| Fass, RJ; Helsel, VL | 2 |
| Clarke, AM; Zemcov, SJ | 1 |
| Davies, S; Sparham, PD; Spencer, RC | 1 |
| Berardi-Grassias, LD; Roy, O | 1 |
| Attisso, MA; Dusart, G; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Habiyaremye, I; Vandepitte, J; Verbist, L | 1 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC; Regamey, P | 1 |
| Pattyn, SR; Van Caekenberghe, DL; Verhoeven, JR | 1 |
| Bébéar, C; Fourche, J; Mormède, M; Texier-Maugein, J | 1 |
| Chan, KP; Koh, ST; Sng, EH | 1 |
| Husson, M; Klastersky, J; Van der Auwera, P | 1 |
| Bayer, AS; Hirano, L; Yih, J | 1 |
| Fay, M; Gougerot-Pocidalo, MA; Roche, Y | 2 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| Ashby, J; Donovan, I; Webberly, JM; Wise, R | 1 |
| Duval, J; Leclercq, R; Soussy, CJ | 1 |
| Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| de Micco, P; Gevaudan, MJ; Gulian, C; Lagier, P; Mallet, MN; Terriou, P | 1 |
| Bebear, C; de Barbeyrac, B; Quentin, C; Renaudin, H | 1 |
| Benbachir, M; el Filali, KM; el Mdaghri, N; Hajji, M; Himmich, H | 1 |
| Bremner, DA; Dickie, AS; Singh, KP | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Campbell, ME; Clarke, AM; Zemcov, SJ | 1 |
| Borsa, F; Humbert, G | 1 |
| Montay, G; Tassel, JP | 1 |
| Pilliot, J; Ronco, E | 1 |
| Dabernat, H; Delmas, C; Lareng, MB | 1 |
| Daguet, GL; Delisle-Mizon, F; Lesage, D; Vergez, P | 1 |
| Bergogne-Berezin, E; Joly-Guillou, ML | 1 |
| Bryskier, A; Devos, J; Dubreuil, L; Romond, C | 1 |
| Bayer, AS; Greenberg, DP; Yih, J | 1 |
| Fourrier, F; Gouin, F; Junginger, W; Martin, C; Prieur, BL | 1 |
| Gres, JJ; Lerebours, G; Lucet, JC; Piguet, H; Tilly, H | 1 |
| Fillastre, JP; Humbert, G; Lemeland, JF; Thauvin, C | 1 |
| Höffler, D; Koeppe, P; Schäfer, I; Sörgel, F | 1 |
| Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L | 1 |
| Cattier, B; Gavignet, M; Goudeau, A; Koubaa, N; Quentin, R | 1 |
| Berlioux, J; Daguet, GL; Mugnier, P; Pasteau, C; Ygout, JF | 1 |
| Caillon, J; Dellamonica, P; Drugeon, HB | 1 |
| Benevent, D; Denis, F; Lagarde, C; Mounier, M | 1 |
| Deforges, L; Duval, J; Le Van Thoi, J; Soussy, CJ | 1 |
| Fisch, A; Forestier, F; Lafaix, C; Meulemans, A; Montay, G; Salvanet, A | 1 |
| Adenis, JP; Denis, F; Mounier, M | 1 |
| Baron, D; Drugeon, HB; Meignier, M; Montay, G; Potel, G; Touzé, MD | 1 |
| Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F | 1 |
| Martin, E; Nauciel, C | 1 |
| Descotes, J; Lombard, JY | 1 |
| Desnottes, JF | 1 |
| Boland, DM; de Jong, D; MacLaren, DM; van Gestel, WC | 1 |
| Bersani, C; Bertoletti, R; Fietta, A; Gialdroni Grassi, G; Santagada, T | 1 |
| Lauwers, S; Naessens, A; Pierard, D; Vincken, W | 1 |
| Dournon, E; Pocidalo, JJ; Rajagopalan, P; Vilde, JL | 1 |
| Bassoullet, MT; Bruel, J; Desnottes, JF; Jacotot, F; Niel, G | 1 |
| Djebbar, F; Fourtillan, JB; Frydman, AM; Gaillot, J; Le Roux, Y; Lefebvre, MA | 1 |
| Chazal, J; Djebbar, F; Dow, J; Frydman, AM; Gaillot, J; Janny, P; Woehrle, R | 1 |
| Brion, N; Lefevre, JJ; Lessana, A; Montay, G; Mosset, F | 1 |
| Rapin, M | 1 |
| Fourtillan, JB | 1 |
| Acar, JF; Bergogne-Berezin, E; Christol, D; Courtieu, AL; Duval, J; Fleurette, J; Lareng, MB; Morel, C; Soussy, CJ; Thabaut, A | 1 |
| Modaï, J | 1 |
| Duerden, BI; Geary, I; Jones, BM; Lee, ME | 1 |
| Andrews, J; Manek, N; Wise, R | 1 |
| Dubayle, P; Fisch, A; Forestier, F; Haroche, G; Lafaix, C; Montay, G; Salvanet, A | 1 |
| Davies, BI; Storey, BE | 1 |
| Barry, AL; Fuchs, PC; Jones, RN; Thornsberry, C | 1 |
| Rietbrock, N; Staib, AH | 1 |
| Andrews, JM; Griggs, D; Lister, D; McNulty, CA; Wise, R | 1 |
| Boogaerts, MA; Malbrain, S; Scheers, W; Verwilghen, RL | 1 |
| Appelbaum, PC; Sollenberger, L; Spangler, SK | 1 |
| Dabbs, DJ; Limb, DI; Spencer, RC | 1 |
| Desnottes, JF; Diallo, N; Moret, G; Santonja, R | 1 |
| Arpi, M; Bentzon, MW; Gahrn-Hansen, B; Søgaard, P | 1 |
| Mazzei, T; Nicoletti, P; Periti, P | 1 |
| Barry, AL; Jones, RN | 1 |
| Wolff, M | 1 |
| Pattyn, SR | 1 |
| Smith, CR | 1 |
| Bebear, C; Lafferriere, C; Noury, P; Quentin, C; Saivin, S | 1 |
| Albengres, E; Chevais, M; Reinert, P; Riant, P; Rondeau, MC; Tillement, JP; Tobelem, R | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| Kawane, H; Niki, Y; Soejima, R; Sumi, M; Umeki, S | 1 |
| Comhaire, FH | 1 |
| Cheong, YM; Joseph, PG; Koay, AS | 1 |
| Beauchant, M; Becq-Giraudon, B; Bouquet, S; Breux, JP; Rochard, E; Silvain, C | 1 |
| Descotes, J; Evreux, JC; Lombard, JY | 1 |
| Debbia, E; Nicoletti, G; Schito, GC; Speciale, A | 1 |
| Ganeval, D; Hannedouche, T; Jungers, P; Montay, G; Prieur, B | 1 |
| Beauchant, M; Becq-Giraudon, B; Bouquet, S; Breux, JP; Cardey, J; Fourtillan, JP; Silvain, C | 1 |
| Ellis-Pegler, RB; Isaacs, RD | 1 |
| Desnottes, JF; Fleurette, J; Janin, N; Meugnier, H; Woehrle, R | 1 |
| Baars, AM; van Herwaarden, CL; Vree, TB; Wijnands, WJ | 2 |
| Borner, K; Glatzel, P; Höffken, G; Koeppe, P; Lode, H; Olschewski, P; Prinzing, C; Reimnitz, D; Sievers, B; Wiley, R | 1 |
| Andrews, JM; Ashby, JP; McLeod, A; Webberley, JM; Wise, R | 1 |
| Akalin, E; Baykal, M | 1 |
| Bron, A; Delbosc, B; Estavoyer, JM; Talon, D | 1 |
| Dournon, E; Rajagopalan, P; Vildé, JL | 1 |
| Bron, A; Delbosc, B; Estavoyer, JM; Montard, M; Prost, F; Talon, D | 1 |
| Etienne, D; Fay, M; Forest, N; Gougerot-Pocidalo, MA; Pocidalo, JJ; Roche, Y | 1 |
| Auzepy, P; Richard, C; Singlas, E; Sultan, E | 1 |
| Boerema, JB; Crombach, W; Pauwels, R; Scheepers, J | 1 |
| Hackbarth, CJ; Sande, MA; Shibl, AM | 1 |
| Bouillet, L; Husson, MO; Izard, D; Leclerc, H | 1 |
| Caillet, R; Desnottes, JF; Diallo, N; Hébert, JP | 1 |
| Berardi-Grassias, L; Bigel, ML; Boisivon, A; Chauvière, P; Guiomar, C; Macheboeuf, F | 1 |
| Giroir, AM; Grosset, JH; Guelpa-Lauras, CC; Perani, EG | 1 |
| Bebear, C; Laurent, C; Noury, P; Quentin, C; Saivin, S | 1 |
| Cunci, R; Danan, G; Erlinger, S; Montay, G | 1 |
| Bryskier, A; Husson, MO; Izard, D; Leclerc, H | 1 |
| Davies, BI; Maesen, FP; Teengs, JP | 1 |
| Bryskier, A; Chantot, JF | 1 |
| Ligtvoet, EE; Wickerhoff-Minoggio, T | 1 |
| Bariety, J; Cunci, R; Jacquot, C; Montay, G | 1 |
| Boerema, JB; Dirksen, MS; Hekster, YA; Waas, RJ | 1 |
| Gille, Y; Marcatello, A; Robert, D; Tigaud, S; Vincent, P | 1 |
| Bouletreau, P; Chomarat, M; Flandrois, JP; Fournier, G; Joulie, V | 1 |
| Chu, DT; Claiborne, AK; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG; Pihuleac, E | 1 |
| Bryskier, A; Croize, J; Le Noc, P; Robert, J | 1 |
| Bertrand, A; Janbon, F; Jonquet, O; Jourdan, J; Santoni, A | 1 |
| Blain, Y; Le Hir, A; Montay, G; Roquet, F | 1 |
| Bebear, C; Cantet, P; Quentin, C; Renaudin, H | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Husson, MO; Izard, D; Leclerc, H | 1 |
| Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
| Delavault, P; Soussy, CJ | 1 |
| Davidson, RJ; Drobot, GR; Hoban, DJ; Karlowsky, JA; Philips, R; Zhanel, GG | 1 |
| Courvalin, P; Desplaces, N; Duval, J; Tankovic, J | 1 |
| Billebaud, T; Boccon-Gibod, L; Delmas, V; Villers, A | 1 |
| Iakovlev, VP | 1 |
| Griffiths, NM; Hirst, BH; Simmons, NL | 1 |
| Eugène, C; Wesenfelder, L | 1 |
| Colau, JC; Delavault, P; Guibert, J; Mazeman, E | 1 |
| Ahmedy, A; Khardori, N; Toama, M; Yassien, M | 1 |
| Abanmi, N; Al-Khamis, KI; El Sayed, N; Zaghloul, I | 1 |
| Prasad, G; Srivastava, PK; Thacker, AK; Verma, RB | 1 |
| Hostacká, A | 1 |
| Besednova, NN; Shubin, FN; Zaĭtseva, EA | 2 |
| Delavault, P; Lozniewski, A; Moreau, JL; Royer, RJ; Royer-Morrot, MJ; Trackoen, G | 1 |
| Ioannou, PC; Lianidou, ES; Veiopoulou, CJ | 1 |
| Carli, P; De Mauleon De Bruyere, P; Gadea, JF; Levadoux, M; Perre, C | 1 |
| Sieb, JP | 1 |
| Ballesta, S; Benedí, VJ; García, I; Hernández-Allés, S; Martínez-Martínez, L; Pascual, A | 1 |
| Adolphe, M; Bernard-Beaubois, K; Hayem, G; Hecquet, C; Rat, P | 1 |
| Bouquet, S; Couet, W; Courtois, P; Delon, A; Pariat, C | 1 |
| Antolic, G; Grabnar, I; Kozjek, F; Mrhar, A; Suturkova, LJ | 1 |
| Bouquet, S; Couet, W; Delon, A; Giraudon, M; Levasseur, LM | 1 |
| Besednova, NN; Shubin, FN; Zaĭtseva, EF | 1 |
| Khardori, N; Yassien, M | 1 |
| Aquilini, D; Bartoloni, A; Paradisi, F | 1 |
| Dong, C; Feng, XH; Li, JQ | 1 |
| Bois, FY; Brochot, C; Couet, W; Gelman, A; Marchand, S | 1 |
| Köşem, M; Ozbek, H; Tuncay, I; Unal, O | 1 |
| Cardines, R; Gentile, G; Giuliano, M; Mandelli, F; Martino, P; Pantosti, A; Santilli, S | 1 |
| Arcese, W; Gentile, G; Giuliano, M; Martino, P; Micozzi, A; Pantosti, A | 1 |
| Malik, JK; Pant, S; Rao, GS; Sastry, KV; Tripathi, HC | 1 |
| Andreeva, I; Rafalsky, V; Rjabkova, E | 1 |
| Chen, X; Hua, H; Ji, C; Lin, X; Liu, Y; Tang, S; Yue, Z | 1 |
| Kokot, S; Ni, Y; Wang, Y | 1 |
| Dimitrova, D; Dinev, T; Kanelov, I; Lashev, L; Moutafchieva, R; Pandova, B; Yanev, S | 1 |
| Beytemur, O; Gulmez, T; Kaleagasioglu, F; Mutlu, Z; Olcay, E; Olgac, V | 1 |
| Betlejewska-Kielak, K; Biernacka, J; Grudzień, M; Kłosińska-Szmurło, E; Mazurek, AP; Pluciński, FA | 1 |
| Gao, Y; Ji, Y; Lin, Y; Lin, Z; Lu, Y; Yang, Y; Zhang, L | 1 |
| Gui, D; Hua, P; Krebs, P; Wu, S; Ying, G; Zhang, J | 1 |
| Guo, L; Kuang, H; Lei, X; Liu, L; Xu, C; Xu, L | 1 |
| Bouquet, S; Couet, W; Courtois, P; Delon, A; Huguet, F; Vierfond, JM | 1 |
| Bouquet, S; Couet, W; de Boer, AG; de Lange, EC; Delon, A; Marchand, S; van den Berg, D; van der Sandt, IC | 1 |
| Chaves, J; del Carmen Conejo, M; Hernández, G; Joyanes, P; Martínez-Martínez, L; Pascual A, A; Perea, EJ | 1 |
10 review(s) available for norfloxacin and pefloxacin
| Article | Year |
|---|---|
Quinolone hybrids and their anti-cancer activities: An overview.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Quinolones; Structure-Activity Relationship | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Pharmacokinetics of quinolones in renal insufficiency.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1990 |
The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
Topics: Anti-Bacterial Agents; Bacteria; Blood Proteins; Ciprofloxacin; Enoxacin; Fluorine; Humans; Kidney; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Protein Binding; Quinolines; Urinary Tract Infections | 1985 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
Topics: Ciprofloxacin; Enoxacin; Humans; Intestines; Naphthyridines; Norfloxacin; Ofloxacin; Oropharynx; Oxazines; Pefloxacin; Quinolines | 1988 |
[Quinolones and phagocytosis].
Topics: Animals; Anti-Bacterial Agents; Humans; Macrophages; Neutrophils; Norfloxacin; Pefloxacin; Phagocytosis; Rats | 1987 |
Quinolones.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Pharmacokinetics of fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin | 1993 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolones; Humans; Levofloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Randomized Controlled Trials as Topic | 2006 |
12 trial(s) available for norfloxacin and pefloxacin
| Article | Year |
|---|---|
Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacteremia; Bacterial Infections; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Norfloxacin; Pefloxacin | 1992 |
Single-dose pefloxacin versus five-days treatment with norfloxacin in uncomplicated cystitis in women.
Topics: Adult; Cystitis; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Middle Aged; Norfloxacin; Pefloxacin; Urinary Tract Infections | 1990 |
Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients.
Topics: Adult; Bone Marrow Transplantation; Drug Resistance, Microbial; Feces; Female; Humans; Immunosuppression Therapy; Intestines; Leukemia; Male; Mouth; Norfloxacin; Pefloxacin; Staphylococcus; Whole-Body Irradiation | 1989 |
[Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin].
Topics: Anti-Infective Agents; Bacterial Infections; Bronchopneumonia; Humans; Norfloxacin; Pefloxacin | 1986 |
[Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].
Topics: Agranulocytosis; Anti-Infective Agents; Cefotaxime; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Feces; Fever; Focal Infection; Humans; Leukemia; Neutropenia; Norfloxacin; Pefloxacin; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1987 |
Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.
Topics: Adult; Drug Combinations; Female; Humans; Male; Norfloxacin; Paratyphoid Fever; Pefloxacin; Prospective Studies; Random Allocation; Salmonella paratyphi A; Salmonella paratyphi B; Salmonella typhi; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1988 |
[Diffusion of fluoroquinolones in the aqueous humor and crystalline lens].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Diffusion; Humans; Lens, Crystalline; Middle Aged; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit.
Topics: Bacterial Infections; Clinical Trials as Topic; Critical Care; Drug Resistance, Microbial; Humans; Norfloxacin; Pefloxacin; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections | 1987 |
[Acute cystitis in women over 50 years of age. Efficacy of pefloxacin with single dose and norfloxacin for 10 days].
Topics: Acute Disease; Administration, Oral; Aged; Cystitis; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Middle Aged; Norfloxacin; Pefloxacin | 1993 |
Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary; Chromatography, Liquid; Epithelium; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Pefloxacin; Regression Analysis; Urinary Bladder | 1996 |
Kinetics of 4-fluoroquinolones permeation into saliva.
Topics: Adult; Anti-Infective Agents; Biological Transport; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Monitoring; Humans; Male; Norfloxacin; Ofloxacin; Pefloxacin; Saliva | 1999 |
Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens.
Topics: Adipose Tissue; Animals; Anti-Bacterial Agents; Chickens; Drug Residues; Kidney; Liver; Muscle, Skeletal; Norfloxacin; Pefloxacin; Skin; Tissue Distribution | 2005 |
244 other study(ies) available for norfloxacin and pefloxacin
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Aerobiosis; Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Infections; Cattle; Cattle Diseases; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Molecular Structure; Pasteurella Infections; Quinolones; Structure-Activity Relationship; Swine; Swine Diseases | 1992 |
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
Topics: Animals; Anti-Infective Agents; Cricetinae; Cricetulus; Fluoroquinolones; Microbial Sensitivity Tests; Structure-Activity Relationship | 1992 |
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Bacterial Infections; Female; Injections, Subcutaneous; Mice; Microbial Sensitivity Tests; Photosensitivity Disorders; Structure-Activity Relationship | 1992 |
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Ciprofloxacin; Escherichia coli Infections; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pharmaceutical Preparations; Prodrugs; Structure-Activity Relationship | 1988 |
Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships.
Topics: Anti-Bacterial Agents; Escherichia coli; Quinolines; Structure-Activity Relationship | 1984 |
Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids.
Topics: Anti-Bacterial Agents; Bacteria; Quinolines; Structure-Activity Relationship | 1980 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Chemometric studies on the bactericidal activity of quinolones via an extended VolSurf approach.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Escherichia coli; Models, Molecular; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Quinolones; Staphylococcus aureus; Thermodynamics | 2004 |
Synthesis and antibacterial activity of the 4-quinolone-3-carboxylic acid derivatives having a trifluoromethyl group as a novel N-1 substituent.
Topics: Anti-Bacterial Agents; Carboxylic Acids; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus; Streptococcus pneumoniae | 2005 |
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.
Topics: Amino Acid Substitution; Base Sequence; DNA Gyrase; DNA Mutational Analysis; DNA Primers; DNA Probes; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Nucleic Acid Denaturation; Point Mutation; Polymerase Chain Reaction; Streptococcus pneumoniae; Thermodynamics | 2008 |
Interaction of drug based binuclear mixed-ligand complexes with DNA.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Ciprofloxacin; Cobalt; DNA, Bacterial; Ligands; Magnetic Resonance Spectroscopy; Magnetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Oxidation-Reduction; Spectrophotometry, Infrared; Structure-Activity Relationship; Temperature; Viscosity | 2009 |
Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model.
Topics: Absorption; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Transport, Active; Cell Line; Cell Membrane Permeability; Cyclosporins; Diffusion; Drug Interactions; Drug Resistance, Bacterial; Epithelial Cells; Fluoroquinolones; Kinetics; Lipids; Lung | 2010 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Species Specificity | 1992 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
Pefloxacin and metabolites removal in continuous hemofiltration with dialysis.
Topics: Blood Proteins; Hemofiltration; Humans; Norfloxacin; Pefloxacin; Protein Binding; Renal Dialysis | 1991 |
In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Francisella tularensis; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Tularemia | 1991 |
Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; Eye; Injections, Intramuscular; Norfloxacin; Pefloxacin; Pigmentation; Rabbits; Spectrophotometry, Ultraviolet | 1991 |
Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Physiological Phenomena; Ciprofloxacin; Culture Media; Humans; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Staphylococcus aureus | 1991 |
Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics.
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; DNA; DNA Repair; Liver; Norfloxacin; Ofloxacin; Pefloxacin; Phosphorus Radioisotopes; Rats | 1991 |
Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Norfloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
Influence of new quinolones on normal immune capabilities.
Topics: Animals; Anti-Infective Agents; Antibody Formation; Ciprofloxacin; Hypersensitivity, Delayed; Immunity, Cellular; Injections, Intramuscular; Male; Mice; Norfloxacin; Ofloxacin; Pefloxacin; Phagocytosis | 1990 |
Quinolone pharmacokinetics and metabolism.
Topics: Administration, Oral; Anti-Infective Agents; Biological Availability; Biotransformation; Ciprofloxacin; Enoxacin; Fleroxacin; Half-Life; Humans; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin | 1990 |
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; In Vitro Techniques; Klebsiella pneumoniae; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype | 1990 |
The influence of quinolones on the faecal flora.
Topics: Anti-Infective Agents; Ciprofloxacin; Enterobacteriaceae; Feces; Humans; Intestines; Norfloxacin; Ofloxacin; Pefloxacin | 1990 |
[Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Topics: Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Phenotype; Staphylococcus aureus | 1990 |
[Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
Topics: Bacteria; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Species Specificity | 1989 |
Antimicrobial activity and interaction of pefloxacin and its principal metabolites. Collaborative Antimicrobial Susceptibility Testing Group.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Staphylococcus; Streptococcus | 1989 |
[Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
Topics: Anti-Infective Agents; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Serratia marcescens | 1989 |
Antibacterial and plasmid curing activity of lomefloxacin in vitro.
Topics: Anti-Infective Agents; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Plasmids; Pseudomonas aeruginosa; Quinolones; Staphylococcus aureus | 1989 |
[In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mycobacterium; Norfloxacin; Ofloxacin; Pefloxacin | 1989 |
The role of quinolones in staphylococcal infection.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Norfloxacin; Ofloxacin; Pefloxacin; Staphylococcal Infections | 1989 |
Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
Topics: Electrophoresis, Agar Gel; Escherichia coli; Microbial Sensitivity Tests; Norfloxacin; Novobiocin; Pefloxacin; Plasmids; Quinolines; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1987 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Male; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Proteus mirabilis; Rats; Rats, Inbred Strains | 1986 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Osteomyelitis; Oxazines; Pefloxacin; Quinolines; Respiratory Tract Infections; Sexually Transmitted Diseases; Surgical Wound Infection; Urinary Tract Infections | 1987 |
[Passage of pefloxacine into the synovial fluid].
Topics: Anti-Infective Agents; Arthritis, Infectious; Female; Humans; Norfloxacin; Pefloxacin; Staphylococcal Infections; Synovial Fluid | 1985 |
The in-vitro comparative activity of quinolones against bacteria from urinary tract infections in general practice.
Topics: Anti-Infective Agents, Urinary; Bacteria; Ciprofloxacin; Enterococcus faecalis; Escherichia coli; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Staphylococcus; Urinary Tract Infections | 1986 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Neisseria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pneumococcal Infections; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 1986 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxacin; Prostatitis; Pseudomonas Infections; Quinolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Bladder, Neurogenic; Urinary Tract Infections | 1986 |
Quinolones and colonization resistance in human volunteers.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Digestive System; Feces; Female; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines | 1986 |
Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Spectrophotometry, Ultraviolet | 1986 |
[Treatment of septicemia and endocarditis with pefloxacine. 15 cases].
Topics: Adult; Aged; Anti-Infective Agents; Child; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Norfloxacin; Pefloxacin; Sepsis | 1986 |
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Ciprofloxacin; Clostridium; Enoxacin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in-vitro activity of pefloxacin.
Topics: Acinetobacter; Aeromonas; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacteroides; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gardnerella vaginalis; Haemophilus influenzae; Lactams; Neisseria gonorrhoeae; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Quinolines; Streptococcus | 1986 |
In-vitro activity of newer quinolones against aerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Calcium; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Magnesium Sulfate; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas; Quinolines; Sulfates; Zinc; Zinc Sulfate | 1986 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin | 1986 |
Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Clostridium; Enoxacin; Fluoroquinolones; Humans; Infant, Newborn; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Photoonycholysis induced by the fluoroquinolones pefloxacine and ofloxacine. Report on 2 cases.
Topics: Aged; Aged, 80 and over; Drug Eruptions; Humans; Male; Mycosis Fungoides; Nail Diseases; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Photosensitivity Disorders; PUVA Therapy | 1986 |
[Decreased absorption of pefloxacin by gastric antacids. Preliminary study].
Topics: Aged; Antacids; Drug Interactions; Female; Humans; Norfloxacin; Pefloxacin | 1986 |
[Enzymologic aspect of piperacillin combinations].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Therapy, Combination; Enterobacter; Enzyme Induction; Hydrolysis; Norfloxacin; Pefloxacin; Piperacillin; Pseudomonas aeruginosa | 1986 |
[Salvage treatment of multi-resistant pulmonary tuberculosis. Efficacy of pefloxacine].
Topics: Adult; Anti-Infective Agents; Drug Resistance, Microbial; Female; Humans; Norfloxacin; Pefloxacin; Tuberculosis, Pulmonary | 1987 |
Drug-induced photo-onycholysis. Three subtypes identified in a study of 15 cases.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Doxycycline; Drug Eruptions; Female; Humans; Male; Middle Aged; Nail Diseases; Nails; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Photosensitivity Disorders; PUVA Therapy; Tetracycline; Trioxsalen; Ultraviolet Rays | 1987 |
[Biotransformation of selected gyrase inhibitors].
Topics: Anti-Infective Agents; Biotransformation; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
[Rickettsiaceae infections and fluoroquinolones].
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Boutonneuse Fever; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pregnancy; Q Fever; Rifampin | 1988 |
Activity of ofloxacin against Mycobacterium leprae in the mouse.
Topics: Animals; Anti-Bacterial Agents; Dapsone; Female; Leprosy; Mice; Mycobacterium leprae; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Prothionamide | 1988 |
[Recurrent infections caused by Salmonella typhimurium].
Topics: Anti-Bacterial Agents; Child, Preschool; Female; Humans; Immunologic Deficiency Syndromes; Neutrophils; Norfloxacin; Pefloxacin; Recurrence; Salmonella Infections; Salmonella typhimurium | 1988 |
Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
Topics: Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; R Factors | 1988 |
[Dependence of the bactericidal activity and mutant selection of 4-quinolones on their serum concentration levels].
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Mutation; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Staphylococcus aureus | 1986 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Drug Resistance, Microbial; Enterobacteriaceae; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus | 1986 |
In-vitro activity of pefloxacin compared to other antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Citrobacter; Enterobacter; Enterobacteriaceae; Enterococcus faecalis; Escherichia coli; Haemophilus; Klebsiella; Norfloxacin; Pefloxacin; Proteus; Pseudomonas aeruginosa; Salmonella; Shigella; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 1986 |
The diffusion of pefloxacin into bone and the treatment of osteomyelitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Bone and Bones; Calcium; Chromatography, High Pressure Liquid; Diffusion; Enterococcus faecalis; Escherichia coli; Female; Fluorine; Humans; Male; Middle Aged; Norfloxacin; Osteomyelitis; Pefloxacin; Phosphorus; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus; Tissue Distribution | 1986 |
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Topics: Amikacin; Ampicillin; Cephalothin; Drug Combinations; Drug Interactions; Enterobacteriaceae; Escherichia coli; Female; Humans; Infusions, Parenteral; Kanamycin; Klebsiella pneumoniae; Male; Norfloxacin; Oxacillin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Ticarcillin | 1986 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
[In-vivo bacteriostatic and bactericidal activity of pefloxacine].
Topics: Blood Bactericidal Activity; Enterobacteriaceae; Humans; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Time Factors; Urinary Tract Infections | 1986 |
Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Ceftazidime; Citrobacter; Drug Interactions; Enterobacter; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Serratia marcescens | 1987 |
Susceptibility of Rickettsia conorii and R. rickettsii to pefloxacin, in vitro and in ovo.
Topics: Animals; Chick Embryo; Norfloxacin; Pefloxacin; Rickettsia; Rickettsia rickettsii; Vero Cells | 1987 |
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of the new 4-quinolone compound Ro 23-6240.
Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Naphthyridines; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Topics: Acinetobacter; Anti-Bacterial Agents; Cross Infection; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nicotinic Acids; Norfloxacin; Pefloxacin; Pipemidic Acid; Pseudomonas aeruginosa; Staphylococcus | 1987 |
[In vitro study of the combination of pefloxacin with other antibiotics against Pseudomonas aeruginosa and Streptococcus group D].
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; In Vitro Techniques; Norfloxacin; Pefloxacin; Phenotype; Pseudomonas aeruginosa | 1987 |
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1987 |
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections | 1987 |
In vitro activity of five new quinolones against cultivable mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Susceptibility of Neisseria gonorrhoeae to pefloxacin.
Topics: 4-Quinolones; Anti-Bacterial Agents; Humans; Neisseria gonorrhoeae; Norfloxacin; Pefloxacin; Penicillinase; Quinolines; Quinolones | 1987 |
Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Ceftazidime; Drug Interactions; Humans; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Piperacillin; Pseudomonas aeruginosa; Time Factors | 1988 |
Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftazidime; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 1988 |
Enhancement of interleukin 2 production by quinolone-treated human mononuclear leukocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; In Vitro Techniques; Interleukin-2; Kinetics; Leukocytes, Mononuclear; Lymphocyte Activation; Mitomycin; Mitomycins; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Receptors, Immunologic; Receptors, Interleukin-2 | 1988 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
Intraperitoneal penetration of pefloxacin.
Topics: Anti-Infective Agents; Humans; Norfloxacin; Pefloxacin; Peritoneal Cavity | 1988 |
[In vitro antibacterial activity of piperacillin/quinolone combinations].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Synergism; Escherichia coli; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens | 1988 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin | 1988 |
[Sensitivity of 7 mycobacterial species to new quinolones].
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sulfamethoxazole; Thienamycins; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Mycoplasmataceae; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Quinolones; Ureaplasma | 1988 |
In-vitro activity of fleroxacin compared with three other quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Enoxacin; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin | 1985 |
[Treatment of urinary tract infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Female; Humans; Lactams; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Prostatitis; Urinary Tract Infections | 1985 |
Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Male; Nalidixic Acid; Norfloxacin; Pefloxacin; Prostate | 1985 |
[Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Topics: Coagulase; Methicillin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Penicillin Resistance; Staphylococcus; Staphylococcus aureus | 1985 |
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria meningitidis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Streptococcus pneumoniae | 1985 |
[Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Topics: Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Pseudomonas; Pseudomonas aeruginosa; Quinolines | 1985 |
[Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Topics: Acinetobacter; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1985 |
[Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
Topics: Bacteria, Anaerobic; Bacteroides; Clostridium; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1985 |
Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Infective Agents; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rabbits; Random Allocation; Staphylococcal Infections; Vancomycin | 1988 |
Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cross Infection; Female; Humans; Lung Abscess; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia; Prospective Studies; Respiration, Artificial | 1988 |
Neurological toxicity related to pefloxacin.
Topics: Aged; Anti-Infective Agents; Female; Humans; Middle Aged; Nervous System Diseases; Norfloxacin; Pefloxacin | 1988 |
Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Infective Agents; Endocarditis, Bacterial; Fosfomycin; Male; Methicillin; Norfloxacin; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Staphylococcal Infections | 1988 |
Pharmacokinetics of pefloxacin in normal and impaired renal function.
Topics: Adult; Anti-Bacterial Agents; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Norfloxacin; Pefloxacin | 1988 |
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections | 1988 |
In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Enoxacin; Female; Genital Diseases, Female; Genital Diseases, Male; Haemophilus; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1988 |
[Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Norfloxacin; Pefloxacin; Phenotype; Thienamycins | 1988 |
[Synergy, addition, indifference, antagonism and dominance. Dominance and antibiotic combination].
Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus aureus; Time Factors; Vancomycin | 1987 |
[Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics].
Topics: Adult; Aged; Anti-Infective Agents; Drug Tolerance; Humans; Kidney Failure, Chronic; Middle Aged; Norfloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
[In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
[Intraocular penetration of pefloxacin in man and rabbit. The aqueous humor and vitreous body].
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Infective Agents; Aqueous Humor; Humans; Middle Aged; Norfloxacin; Ophthalmologic Surgical Procedures; Pefloxacin; Premedication; Rabbits; Staphylococcal Infections; Vitreous Body | 1987 |
[Pharmacokinetics of pefloxacin in burn patients].
Topics: Adult; Analysis of Variance; Anti-Infective Agents; Burns; Half-Life; Humans; Infusions, Intravenous; Middle Aged; Norfloxacin; Pefloxacin | 1987 |
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen | 1987 |
[Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chloramphenicol; Female; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Norfloxacin; Pefloxacin; Salmonella Infections, Animal; Salmonella typhimurium | 1987 |
[Antibiotics and chemotaxis in agarose. The role of incubation conditions and application to several fluoroquinolones].
Topics: Anti-Infective Agents; Cell Movement; Chemotaxis, Leukocyte; Doxycycline; Humans; Neutrophils; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Sepharose | 1987 |
Fluoroquinolone derivatives: effects on neutrophil functional tests.
Topics: Anti-Infective Agents; Candida albicans; Chemotaxis, Leukocyte; Ciprofloxacin; Humans; In Vitro Techniques; Neutrophils; Norfloxacin; Ofloxacin; Pefloxacin; Phagocytosis; Staphylococcus aureus | 1987 |
Pefloxacin--a laboratory and clinical evaluation of a new quinolone. Based on papers presented at the 14th International Congress of Chemotherapy. Kyoto, Japan, June 1985.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Norfloxacin; Pefloxacin | 1986 |
Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchopneumonia; Cholangitis; Drug Evaluation; Female; Humans; Intensive Care Units; Male; Middle Aged; Norfloxacin; Pefloxacin; Pneumonia | 1986 |
Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis.
Topics: Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Erythromycin; Guinea Pigs; Legionella; Legionnaires' Disease; Male; Norfloxacin; Pefloxacin | 1986 |
Effects of pefloxacin on phagocytosis function of rat macrophages and polymorphonuclear leucocytes.
Topics: Animals; Anti-Infective Agents; Macrophages; Neutrophils; Norfloxacin; Pefloxacin; Phagocytosis; Rats; Rats, Inbred Strains | 1986 |
Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Biological Availability; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Parenteral; Kinetics; Male; Norfloxacin; Pefloxacin; Sex Factors | 1986 |
Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.
Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Hydrocephalus; Infusions, Parenteral; Kinetics; Male; Middle Aged; Norfloxacin; Pefloxacin | 1986 |
Penetration of pefloxacin in human heart valves.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Heart Valves; Humans; Middle Aged; Myocardium; Norfloxacin; Pefloxacin; Tissue Distribution | 1986 |
[Pefloxacin].
Topics: Humans; Norfloxacin; Pefloxacin | 1986 |
[Pharmacokinetic behavior of pefloxacin in man].
Topics: Administration, Oral; Biological Availability; Humans; Kinetics; Norfloxacin; Pefloxacin; Tissue Distribution | 1986 |
[Multicenter study of the activity of pefloxacin on bacteria isolated in a hospital milieu].
Topics: Bacteria; Drug Resistance, Microbial; Hospitals; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1986 |
[Pefloxacin: evaluation and clinical prospects].
Topics: Bacterial Infections; Evaluation Studies as Topic; Female; Humans; Lung Diseases; Male; Meningitis; Norfloxacin; Osteomyelitis; Pefloxacin; Urethritis; Urinary Tract Infections | 1986 |
Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Cross Infection; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Urinary Tract Infections | 1986 |
In-vitro activity of pefloxacin in combination with other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Drug Combinations; Norfloxacin; Pefloxacin | 1986 |
Pefloxacin concentrations in human aqueous humour and lens.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Female; Humans; Infusions, Intravenous; Lens, Crystalline; Male; Middle Aged; Norfloxacin; Pefloxacin | 1986 |
A simple computer program for calculating areas under concentration-time curves.
Topics: Anti-Infective Agents; Cefuroxime; Computers; Humans; Kinetics; Norfloxacin; Pefloxacin; Pharmacology; Software; Sputum | 1986 |
Tentative disk diffusion susceptibility interpretive criteria for pefloxacin.
Topics: Bacteria; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Regression Analysis | 1986 |
Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Ciprofloxacin; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
[Gyrase inhibitors: unwanted central nervous system effects].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Brain Chemistry; Brain Diseases; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Solubility | 1987 |
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Pefloxacin; Quinolines | 1986 |
The comparative pharmacokinetics of five quinolones.
Topics: Administration, Oral; Adult; Ciprofloxacin; Enoxacin; Half-Life; Humans; Infusions, Intravenous; Kinetics; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1986 |
Effects of quinolones on granulocyte function in vitro.
Topics: Anti-Infective Agents; Cell Survival; Ciprofloxacin; Hexosephosphates; Humans; Neutrophils; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Phagocytosis | 1986 |
Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.
Topics: Anti-Infective Agents; Cefpirome; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolines | 1986 |
In-vitro selection of bacteria resistant to the 4-quinolone agents.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Staphylococcus; Streptococcus | 1987 |
Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Humans; Mouth Mucosa; Norfloxacin; Pefloxacin; Staphylococcus aureus | 1987 |
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Therapeutic contribution of the new quinolones].
Topics: Anti-Infective Agents; Bacterial Infections; Biotransformation; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Therapy, Combination; Humans; Kinetics; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.
Topics: Animals; Drug Evaluation, Preclinical; Leprosy; Mice; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
The adverse effects of fluoroquinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Topics: Anti-Bacterial Agents; Drug Antagonism; Drug Interactions; Drug Synergism; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Thienamycins | 1987 |
Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
Topics: Acidosis; Adolescent; Animals; Anti-Infective Agents; Cartilage, Articular; Child; Humans; Infant; Joint Diseases; Norfloxacin; Osteochondritis; Pain; Pefloxacin; Risk | 1987 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
New synthetic quinolone antibacterial agents and serum concentration of theophylline.
Topics: Adult; Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Theophylline | 1987 |
Concentration of pefloxacine in split ejaculates of patients with chronic male accessory gland infection.
Topics: Adult; Chronic Disease; Exocrine Glands; Genital Diseases, Male; Humans; Infertility, Male; Inflammation; Male; Norfloxacin; Pefloxacin; Semen | 1987 |
In-vitro susceptibility of Pseudomonas pseudomallei isolated in Malaysia to some new cephalosporins and a quinolone.
Topics: Cephalosporins; Melioidosis; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas | 1987 |
Decreased erythrocyte penetration of pefloxacin in cirrhotic patients.
Topics: Adult; Aged; Anti-Infective Agents; Blood Proteins; Erythrocytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Pefloxacin; Protein Binding | 1987 |
Polymorphonuclear leucocyte chemotaxis little affected by three quinolones in vitro.
Topics: Anti-Infective Agents; Chemotaxis, Leukocyte; Humans; In Vitro Techniques; Neutrophils; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Enterobacteriaceae; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Staphylococcus; Streptococcus | 1987 |
Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairment.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Biological Assay; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Norfloxacin; Pefloxacin; Uremia | 1987 |
Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.
Topics: Adult; Aged; Anti-Infective Agents; Ascitic Fluid; Diffusion; Female; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Pefloxacin | 1987 |
Successful treatment of Morganella morganii meningitis with pefloxacin mesylate.
Topics: Aged; Anti-Infective Agents; Enterobacteriaceae Infections; Female; Humans; Meningitis; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1987 |
In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
Topics: Anti-Bacterial Agents; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Staphylococcus | 1987 |
Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers.
Topics: Bacteria; Bile; Feces; Female; Humans; Male; Mouth Mucosa; Norfloxacin; Pefloxacin; Saliva | 1987 |
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Enoxacin; Female; Humans; Male; Middle Aged; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
Comparative pharmacokinetics of new quinolones.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Enoxacin; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
Pharmacokinetics and tissue penetration of orally administered pefloxacin.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Blister; Half-Life; Humans; Male; Norfloxacin; Pefloxacin; Tissue Distribution | 1987 |
The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middle Aged; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Theophylline | 1987 |
[Fluoroquinolones].
Topics: Bacteria; Chemical Phenomena; Chemistry; Ciprofloxacin; Enoxacin; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
[Intraocular penetration of a new quinolone in humans: pefloxacin].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Infective Agents; Aqueous Humor; Cataract Extraction; Eye; Female; Humans; Male; Middle Aged; Norfloxacin; Pefloxacin | 1987 |
Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.
Topics: Anti-Bacterial Agents; Doxycycline; Drug Combinations; Erythromycin; Humans; Legionella; Macrophages; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Pefloxacin; Rifampin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
[Intracameral penetration of pefloxacine in man].
Topics: Aged; Anterior Chamber; Anti-Infective Agents; Endophthalmitis; Female; Humans; Male; Middle Aged; Norfloxacin; Pefloxacin | 1986 |
Effects of quinolones on interleukin 1 production in vitro by human monocytes.
Topics: Adult; Anti-Infective Agents; Cell Division; Ciprofloxacin; HLA-DR Antigens; Humans; In Vitro Techniques; Interleukin-1; Kinetics; Monocytes; Norfloxacin; Pefloxacin; Penicillins; Phytohemagglutinins | 1987 |
Comparative effects of quinolones on human mononuclear leucocyte functions.
Topics: Cell Survival; Ciprofloxacin; Humans; Indomethacin; Interleukin-1; Lymphocyte Activation; Lymphocytes; Mercaptoethanol; Monocytes; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Pharmacokinetics of pefloxacin and amikacin administered simultaneously to patients undergoing resuscitation.
Topics: Aged; Amikacin; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Norfloxacin; Pefloxacin; Resuscitation | 1987 |
Efficacy and safety of pefloxacin in the treatment of patients with complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacteriuria; Drug Evaluation; Escherichia coli; Female; Humans; Male; Middle Aged; Norfloxacin; Pefloxacin; Urinary Tract Infections | 1986 |
Evaluation of pefloxacin in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Escherichia coli Infections; Humans; Meningitis; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Rabbits; Time Factors | 1986 |
In vitro activity of pefloxacin.
Topics: Amikacin; Anti-Infective Agents; Cefotaxime; Ceftazidime; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance | 1986 |
[Effects of subinhibitory concentrations of pefloxacine on hemolysin production and adherence of urinary Escherichia coli].
Topics: Bacterial Adhesion; Bacterial Proteins; Child; Escherichia coli; Escherichia coli Proteins; Hemolysin Proteins; Humans; Norfloxacin; Pefloxacin; Urinary Tract Infections | 1986 |
[In vitro study of the pefloxacine-ceftriaxone combination against 18 strains of Acinetobacter].
Topics: Acinetobacter; Ceftriaxone; Drug Combinations; Drug Synergism; In Vitro Techniques; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Time Factors | 1986 |
Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
Topics: Animals; Ciprofloxacin; Dapsone; Female; Half-Life; Kinetics; Leprosy; Mice; Mycobacterium leprae; Norfloxacin; Pefloxacin; Time Factors | 1987 |
[In vitro action of fosfomycin combined with rifampicin, pefloxacin and imipenem on staphylococci (checkerboard method in a liquid medium)].
Topics: Anti-Bacterial Agents; Drug Synergism; Fosfomycin; Humans; Imipenem; Norfloxacin; Pefloxacin; Rifampin; Staphylococcus; Thienamycins | 1987 |
Pefloxacin kinetics in cirrhosis.
Topics: Adult; Aged; Biotransformation; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Infusions, Parenteral; Kinetics; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Pefloxacin | 1985 |
Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid | 1985 |
Pefloxacin in acute exacerbations of chronic bronchitis.
Topics: Anti-Bacterial Agents; Bacteria; Bronchitis; Chronic Disease; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Norfloxacin; Pefloxacin | 1985 |
Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Blood Proteins; Drug Resistance, Microbial; Male; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Protein Binding | 1985 |
In-vitro activity of pefloxacin compared with six other quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Enterobacteriaceae; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolines; Staphylococcus | 1985 |
Pharmacokinetics of pefloxacin in renal insufficiency.
Topics: Adult; Aged; Anti-Infective Agents; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Norfloxacin; Pefloxacin | 1985 |
Pefloxacin-aminophylline interaction.
Topics: Aminophylline; Chemistry, Pharmaceutical; Drug Incompatibility; Humans; Norfloxacin; Pefloxacin | 1985 |
Pefloxacin: evolution of in vitro activity during 18 months of use in an intensive care unit.
Topics: Bacteria, Aerobic; Cross Infection; Humans; Intensive Care Units; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1985 |
[Pharmacokinetic study of pefloxacin in 37 hospital patients under resuscitation].
Topics: Humans; Intensive Care Units; Kinetics; Meningitis; Norfloxacin; Pefloxacin; Pneumonia; Risk; Sepsis | 1985 |
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
Topics: Acinetobacter; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli; Female; Fluorine; Fluoroquinolones; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus; Streptococcus; Structure-Activity Relationship | 1985 |
[Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Topics: Acinetobacter; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pseudomonas aeruginosa | 1985 |
[Pefloxacin: clinical experience].
Topics: Acinetobacter Infections; Adult; Aged; Bacterial Infections; Enterobacteriaceae Infections; Enterococcus faecalis; Female; Humans; Male; Meningitis; Middle Aged; Norfloxacin; Osteitis; Pefloxacin; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1985 |
High-performance liquid chromatography of pefloxacin and its main active metabolites in biological fluids.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Nalidixic Acid; Norfloxacin; Pefloxacin; Time Factors | 1983 |
[Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Topics: 4-Quinolones; Anti-Bacterial Agents; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Ureaplasma | 1983 |
Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas; Quinolines; Respiratory Tract Infections; Trimethoprim; Urinary Tract Infections | 1984 |
In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
Topics: 4-Quinolones; Anti-Infective Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines; Quinolones; Species Specificity | 1984 |
In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin | 1984 |
[Must pefloxacin and norfloxacin be studied separately against bacteria isolated from urinary tract infections by the API-ATB method?].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteriological Techniques; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacteriaceae; Humans; In Vitro Techniques; Norfloxacin; Pefloxacin; Pseudomonas; Urinary Tract Infections | 1995 |
The accumulation of fluoroquinolones in Staphylococcus aureus during the postantibiotic effect.
Topics: Anti-Infective Agents; Biotransformation; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Staphylococcus aureus | 1994 |
In vivo selection during pefloxacin therapy of a mutant of Staphylococcus aureus with two mechanisms of fluoroquinolone resistance.
Topics: Anti-Infective Agents; Bacteriophage Typing; Base Sequence; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Molecular Sequence Data; Mutation; Norfloxacin; Pefloxacin; Polymorphism, Restriction Fragment Length; Serotyping; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Complications of prostatic biopsy. An analysis of a series of 4764 biopsies].
Topics: Anti-Bacterial Agents; Bacterial Infections; Biopsy; France; Humans; Male; Norfloxacin; Pefloxacin; Prostate; Ultrasonography, Interventional | 1993 |
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
Topics: Biological Transport; Carbon Radioisotopes; Cells, Cultured; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Humans; Intestinal Mucosa; Norfloxacin; Ofloxacin; Pefloxacin; Quinolizines | 1994 |
[Peritoneal tuberculosis masked by fluoroquinolones in a patient with liver cirrhosis].
Topics: Anti-Bacterial Agents; Ascites; Drug Therapy, Combination; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Pefloxacin; Peritonitis, Tuberculous | 1993 |
Modulation of biofilms of Pseudomonas aeruginosa by quinolones.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Catheterization; Ciprofloxacin; Glycoproteins; Norfloxacin; Ofloxacin; Pefloxacin; Polysaccharides; Pseudomonas aeruginosa | 1995 |
Determination of pefloxacin and its main active metabolite in human serum by high-performance liquid chromatography.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Humans; Neutropenia; Norfloxacin; Pefloxacin | 1996 |
Headache and visual disturbance.
Topics: Adult; Anti-Infective Agents; Child; Female; Headache; Humans; Intracranial Pressure; Male; Norfloxacin; Papilledema; Pefloxacin; Vision Disorders | 1996 |
[Postantibiotic effects and postantibiotic effects of subinhibitory levels of quinolines on Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; Enoxacin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa | 1996 |
[Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Yersinia pseudotuberculosis | 1996 |
[Elimination of virulence plasmids of Yersinia pseudotuberculosis as affected by fluoroquinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Weight; Norfloxacin; Pefloxacin; Plasmids; Virulence; Yersinia pseudotuberculosis | 1996 |
Application of terbium sensitized fluorescence for the determination of fluoroquinolone antibiotics pefloxacin, ciprofloxacin and norfloxacin in serum.
Topics: Anti-Infective Agents; Cetylpyridinium; Ciprofloxacin; Fluorescence; Humans; Hydrogen-Ion Concentration; Norfloxacin; Organophosphorus Compounds; Pefloxacin; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Terbium; Time Factors | 1997 |
[Repeated rupture of the extensor tendons of the hand due to fluoroquinolones. Apropos of a case].
Topics: Acute Disease; Aged; Anti-Infective Agents; Blood Vessels; Chronic Disease; Female; Hand; Hemosiderosis; Humans; Lymphocytes; Muscular Diseases; Neovascularization, Pathologic; Norfloxacin; Pefloxacin; Recurrence; Rupture, Spontaneous; Tendinopathy; Tendons; Urinary Tract Infections | 1997 |
Fluoroquinolone antibiotics block neuromuscular transmission.
Topics: Animals; Anti-Infective Agents; Electrophysiology; Motor Endplate; Neuromuscular Junction; Norfloxacin; Ofloxacin; Pefloxacin; Rats; Rats, Wistar; Synaptic Transmission | 1998 |
Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains.
Topics: Anti-Infective Agents; Cell Membrane; Drug Resistance, Microbial; Humans; Klebsiella pneumoniae; Norfloxacin; Pefloxacin | 1998 |
In vitro study of cytotoxicity of quinolones on rabbit tenocytes.
Topics: Animals; Anti-Infective Agents; Cell Survival; Cells, Cultured; Collagen; Decorin; Extracellular Matrix Proteins; Mitochondria; Nalidixic Acid; Norfloxacin; Pefloxacin; Proteoglycans; Rabbits; Succinate Dehydrogenase; Tendons | 1998 |
A new approach for early assessment of the epileptogenic potential of quinolones.
Topics: Animals; Anti-Infective Agents; Epilepsy; Mice; Norfloxacin; Pefloxacin; Rabbits; Rats; Rats, Sprague-Dawley | 1998 |
Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite norfloxacin in rats.
Topics: Algorithms; Animals; Anti-Infective Agents; Convulsants; Drug Interactions; Male; Models, Biological; Norfloxacin; Pefloxacin; Rats; Rats, Sprague-Dawley | 1999 |
[The effect of fluoroquinolones on the adhesive properties of different plasmidovars of Yersinia pseudotuberculosis].
Topics: Anti-Infective Agents; Bacterial Adhesion; Ciprofloxacin; Erythrocytes; Humans; In Vitro Techniques; Norfloxacin; Pefloxacin; Plasmids; Serotyping; Yersinia pseudotuberculosis | 2000 |
Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
Topics: Anti-Infective Agents; Bacterial Adhesion; Biofilms; Catheterization; Ciprofloxacin; Dose-Response Relationship, Drug; Glycocalyx; Microbial Sensitivity Tests; Models, Biological; Norfloxacin; Pefloxacin; Staphylococcus epidermidis | 2001 |
Effect of enoxacin, norfloxacin and pefloxacin on polymorphonuclear leukocytes chemiluminescence.
Topics: Anti-Infective Agents; Cell Respiration; Enoxacin; Humans; Luminescent Measurements; Neutrophils; Norfloxacin; Pefloxacin | 1991 |
[Study of filter-paper-substrate delay fluorescence of three quinolones].
Topics: Anti-Infective Agents; Filtration; Hydrogen-Ion Concentration; Norfloxacin; Pefloxacin; Pipemidic Acid; Quinolones; Spectrometry, Fluorescence | 2003 |
Extension of the isobolographic approach to interactions studies between more than two drugs: illustration with the convulsant interaction between pefloxacin, norfloxacin, and theophylline in rats.
Topics: Animals; Drug Interactions; Male; Norfloxacin; Pefloxacin; Rats; Rats, Sprague-Dawley; Seizures; Theophylline | 2004 |
A comparison of effects of fluoroquinolones on fracture healing (an experimental study in rats).
Topics: Animals; Ciprofloxacin; Femoral Fractures; Fluoroquinolones; Fracture Healing; Norfloxacin; Ofloxacin; Pefloxacin; Rats; Rats, Wistar | 2005 |
Anaerobic bacteremia in bone marrow recipients.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria, Anaerobic; Bone Marrow Transplantation; Female; Humans; Male; Norfloxacin; Pefloxacin; Postoperative Complications | 1989 |
Effects of norfloxacin or pefloxacin on the oral and intestinal microflora of bone marrow transplant patients.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; Female; Humans; Male; Norfloxacin; Pefloxacin; Postoperative Complications; Transplantation, Homologous | 1989 |
[Determination of 16 quinolone residues in animal tissues using high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Enrofloxacin; Fluoroquinolones; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2007 |
Multicomponent kinetic spectrophotometric determination of pefloxacin and norfloxacin in pharmaceutical preparations and human plasma samples with the aid of chemometrics.
Topics: Acids; Biomedical Technology; Calibration; Humans; Kinetics; Molecular Structure; Norfloxacin; Pefloxacin; Spectrophotometry | 2008 |
Pharmacokinetics of pefloxacin and its metabolite norfloxacin in male and female ducks.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Cross-Over Studies; Ducks; Female; Injections, Intravenous; Male; Norfloxacin; Pefloxacin | 2008 |
Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats.
Topics: Achilles Tendon; Administration, Oral; Animals; Anti-Bacterial Agents; Ciprofloxacin; Elastic Modulus; Elasticity; Fluoroquinolones; Male; Norfloxacin; Ofloxacin; Pefloxacin; Rats; Rats, Wistar; Tensile Strength | 2011 |
Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability.
Topics: Biological Availability; Buffers; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Absorption; Gatifloxacin; Hydrogen-Ion Concentration; Models, Molecular; Molecular Conformation; Norfloxacin; Octanols; Pefloxacin; Phosphates; Solvents; Static Electricity; Thermodynamics | 2014 |
Antibiotics and antimycotics in waste water treatment plants: Concentrations, removal efficiency, spatial and temporal variations, prediction, and ecological risk assessment.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clotrimazole; Environmental Monitoring; Moxifloxacin; Norfloxacin; Ofloxacin; Pefloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Purification | 2022 |
Occurrences, transport drivers, and risk assessments of antibiotics in typical oasis surface and groundwater.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; Ecosystem; Environmental Monitoring; Groundwater; Norfloxacin; Oxygen; Pefloxacin; Risk Assessment; Water; Water Pollutants, Chemical | 2022 |
Fluorescent strip sensor for rapid and ultrasensitive determination of fluoroquinolones in fish and milk.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Milk; Norfloxacin; Ofloxacin; Pefloxacin | 2023 |
Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Brain; Convulsants; Fluoroquinolones; Infusions, Intravenous; Male; Norfloxacin; Pefloxacin; Quinolones; Rats; Rats, Sprague-Dawley; Seizures; Time Factors; Tissue Distribution | 1997 |
In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Cell Line; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Infusions, Intra-Arterial; Kidney; Mice; Mice, Inbred Strains; Mice, Knockout; Microdialysis; Norfloxacin; Pefloxacin; Recombinant Proteins; Rhodamine 123; Swine; Tissue Distribution; Transfection | 2000 |
[The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
Topics: 4-Quinolones; Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Spain | 2001 |